720-777-0123
- Your Visit
-
Research & Innovation
It starts with a Q:
For the latest cutting-edge research, innovative collaborations and remarkable discoveries in child health, read stories from across all our areas of study in Q: Advances and Answers in Pediatric Health.
My goal is to help patients manage their bleeding or clotting problems in an integrative way that focuses on enjoying life and minimizing long-term effects.
Get to know Beth Warren, MD
- Bleeding Disorders
- Clotting Disorders
- English
Hemophilia, bleeding disorders, clotting disorders, clots in congenital heart disease, heavy menstrual bleeding
Fellowship 0
University of Colorado (Children's Hospital Colorado) Program
Undergraduate 2002
Rice University (TX)
Graduate 2005
Emory University
Medical Education 2009
University of Texas Southwestern Medical Center at Dallas Southwestern Medical School
Residency 2012
University of Colorado (Children's Hospital Colorado) Program
Fellowship 2015
University of Colorado (Children's Hospital Colorado) Program
Graduate 2019
University of Colorado Health Sciences Center
For Patients:
My primary research interest is hemophilia. My research goal is to eliminate breakthrough bleeding by better understanding the biomechanics of joint and muscle bleeding, and by better understanding what factor levels are needed to prevent breakthrough bleeding in specific situations.
My primary research interest is hemophilia. My research goal is to eliminate breakthrough bleeding by better understanding the biomechanics of joint and muscle bleeding, and by better understanding what factor levels are needed to prevent breakthrough bleeding in specific situations.
For Referring Providers:
My primary research interest is hemophilia. My research goal is to eliminate breakthrough bleeding by better understanding the biomechanics of joint and muscle bleeding, and by better understanding what factor levels are needed to prevent breakthrough bleeding in specific situations.
My primary research interest is hemophilia. My research goal is to eliminate breakthrough bleeding by better understanding the biomechanics of joint and muscle bleeding, and by better understanding what factor levels are needed to prevent breakthrough bleeding in specific situations.
Lisa Reaves, MD
Hematology/Oncology - Pediatric
Craig Forester, MD
Hematology/Oncology - Pediatric, Pediatrics
David Harford, MD
Hematology/Oncology - Pediatric, Pediatrics
Sandra Luna-Fineman, MD
Hematology/Oncology - Pediatric
Tim Garrington, MD
Hematology/Oncology - Pediatric
Kristen Eisenman, MD
Hospice & Palliative Medicine, Hematology/Oncology - Pediatric, Pediatrics
